Abstract
Prevalence of end stage renal disease (ESRD) continues to rise in the US. In 2018, there were more than 550,000 ESRD patients receiving maintenance dialysis (USRDS, 2020), accounting for an estimated $35 billion of Medicare ESRD expenditures in 2016 alone. Beginning in 2021, Medicare beneficiaries with ESRD are eligible to enroll in Medicare Advantage plans. This study evaluated the costs of incident dialysis initiation among Medicare Fee-for-Service (FFS) beneficiaries with advanced CKD/ESRD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
